Cook Anne Marie - Nov 28, 2023 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
SVP, GC & Secretary
Signature
/s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Anne Marie Cook
Stock symbol
SAGE
Transactions as of
Nov 28, 2023
Transactions value $
-$22,623
Form type
4
Date filed
11/30/2023, 04:04 PM
Previous filing
Feb 15, 2023
Next filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Award $0 +4K +36.73% $0.00 14.9K Nov 28, 2023 Direct F1, F2
transaction SAGE Common Stock Tax liability -$22.6K -1.17K -7.88% $19.27 13.7K Nov 28, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 25, 2020, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 10,000 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on November 28, 2023, resulting in the vesting of the PSUs as to 4,000 shares.
F2 Reflects beneficial ownership balance which includes 392 shares purchased on June 30, 2023 under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.